Major depression is one of the most common psychiatric disorders, and it often presents in
combination with other medical and psychiatric illnesses. In almost one third of cases, it …

Aims To compare adherence and persistence to oral antidiabetic drugs (OAD) between
patients who are new users of second generation antipsychotics (SGA) versus new users of …

Background In spite of numerous options, the most efficacious treatment for major
depressive disorder (MDD) remains elusive. Algorithm-guided treatments (AGTs) are …

Introduction This post-authorization safety study (PASS) was a commitment to the European
Medicines Agency. Objective This PASS investigated quetiapine as antidepressant …

Purpose The purpose of this study was to compare medication adherence, health care
utilization, and cost among patients receiving adjunctive treatment for major depressive …

Background Augmentation with second-generation antipsychotics (SGAs) represents an
evidence-based psychopharmacotherapeutic strategy recommended in case of insufficient …

Psychiatric disorders have become the biggest cause of non-fatal health burden and are the
major contributor to suicide worldwide. The currently limitations of standard psychotherapy …

Major depressive disorder is one of the most common behavioral disorders and with
aggressive treatment roughly two-thirds of individuals will achieve remission. The remaining …

Background Following a partial response of first-line antidepressant therapy for the
treatment of major depressive disorder (MDD), there is a choice to augment treatment with …

Objective We aimed to unravel potential pharmacokinetic interactions between aripiprazole
and duloxetine. Methods Plasma concentrations of aripiprazole in two groups of 78 patients …